Skip to ContentSkip to Navigation
How to find us dr. R.S.N. (Rudolf) Fehrmann

Research interests

My practical and theoretical background enables me to take an integrative omics approach to identify driver genetic alterations, genes and biological pathways that are relevant for the pathophysiological behaviour and treatment response of tumors and rapidly translate these findings to clinical practice.

In addition to my training as a medical doctor, I completed one full year of Mathematics and Computer Science, after which I continued to obtain my MSc degree in Cognitive Science and Engineering.

In parallel to my medical studies, I worked for several years as a bio-informatician at the Department of Genetics, UMCG. In 2010, I obtained my PhD on high dimensional data analysis for new insights into ovarian cancer phenotypes, after which I continued as an affiliated post-doc at the Departments of Genetics and Medical Oncology (UMCG).

I followed the residency program in Internal Medicine / Medical Oncology and now work as a medical oncologist (staff member) at the department of Medical Oncology at the UMCG. In addition, I am a principal investigator at the Cancer Research Center Groningen in the research programmes: ‘Guided Treatment in Optimal Selected Cancer Patients (GUTS)’ and ‘Damage and Repair in Cancer Development and Cancer (DARE)’.


Colorectal anastomotic leak: Transcriptomic profile analysis

COVID-19 vaccination: the VOICE for patients with cancer

Gallbladder Cancer: Current Insights in Genetic Alterations and Their Possible Therapeutic Implications

Identification and Validation of Esophageal Squamous Cell Carcinoma Targets for Fluorescence Molecular Endoscopy

Improving gene function predictions using independent transcriptional components

mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial

Robust metabolic transcriptional components in 34,494 patient-derived cancer-related samples and cell lines

Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors

Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy

Comparison of Carboplatin With 5-Fluorouracil vs. Cisplatin as Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

Read more


Prangende vragen én antwoorden over artificial intelligence in de zorg

Interview on Artificial Intelligence in Medical Oncology

Vlog: YAG Interdisciplinary Project

Looking back: ECR Lunch on work / life balance

UMCG krijgt subsidie voor onderzoek naar kanker

Press releases: Gene expression analysis identifies global gene dosage sensitivity in cancer

Read more